quercetin

Quercetin is a naturally occurring plant flavonol that belongs to the larger class of flavonoids — a diverse group of polyphenolic compounds widely distributed in fruits, vegetables, tea, grains, and herbs. Its chemical structure, 3,3',4',5,7‑pentahydroxyflavone, comprises a flavone backbone with five hydroxyl groups that confer potent antioxidant activity. The term quercetin derives from Latin (Quercetum, oak forest), where these compounds were historically first characterized. Unlike vitamins and minerals, quercetin is not classified as an essential nutrient and therefore has no established recommended dietary allowance (RDA), but it is among the most abundant flavonoids in the human diet. Typical daily intakes in populations vary widely; estimates suggest average intakes range from around 10 to 50 mg per day depending on dietary patterns. Quercetin exists in foods mainly as glycosides (attached to sugar moieties), which influence its absorption and metabolism. In nature, it contributes to the pigmentation of many plant tissues and serves defensive roles within plants. In humans, quercetin has attracted considerable research interest due to its broad biological activities observed in vitro, animal models, and small clinical trials. While not a nutrient required to prevent deficiency diseases, quercetin’s biochemical activities, including modulation of oxidative stress and inflammation, underpin its alleged potential health benefits, which have been explored in cardiovascular health, metabolic regulation, immunomodulation, allergy relief, and cognitive outcomes.

Quercetin’s principal biological actions stem from its antioxidant capacity — neutralizing reactive oxygen species and attenuating oxidative stress. This antioxidant activity is attributed to its polyhydroxylated structure that can donate electrons to unstable free radicals, stabilizing them and reducing cellular damage. Beyond its direct radical scavenging activity, quercetin modulates signaling pathways involved in inflammation. Several reviews document that quercetin inhibits pro‑inflammatory enzymes and cytokines such as interleukin‑6 (IL‑6) and tumor necrosis factor‑alpha (TNF‑α), contributing to reduced markers of chronic inflammation in preclinical models. In particular, quercetin has been studied for its potential to modulate NF‑κB and mitogen‑activated protein kinase (MAPK) pathways, key regulators of inflammatory gene expression. Some human and animal research has suggested quercetin may reduce systolic and diastolic blood pressure when consumed in supplemental forms, particularly at doses above 500 mg/day, though evidence remains mixed. It is also reported to improve endothelial function and vascular relaxation, mechanisms relevant to cardiovascular risk reduction. Quercetin’s antihistamine effects have been observed in models of allergic response, where it inhibits enzymes involved in histamine release, potentially alleviating symptoms of seasonal allergies, though robust clinical data are limited. In metabolic health research, quercetin exhibits effects on glucose metabolism and insulin sensitivity in animal studies, and some human data report modest reductions in fasting blood glucose levels. Quercetin’s antiviral and antimicrobial actions have been documented in vitro, where it inhibits replication or activity of various pathogens, but clinical relevance remains to be fully demonstrated. Laboratory research also explores anticancer effects, including inhibition of cell proliferation and induction of apoptosis in cancer cell lines, yet high‑quality human trials are lacking and no authoritative body endorses quercetin as a cancer therapy. Cognitive health benefits are proposed based on antioxidant protection of neural tissues and reduced neuroinflammation observed in animal models. Collectively, these activities provide a biochemical basis for quercetin’s potential health effects, but more rigorous, large‑scale human clinical trials are needed to establish definitive benefits and clinical recommendations.

As a non‑essential phytonutrient, quercetin does not have an established recommended dietary allowance (RDA) set by the NIH or Institute of Medicine. Instead, guidelines focus on typical dietary intake and supplemental doses explored in research. Average daily intakes in Western diets are estimated at around 10–50 mg/day depending on consumption of fruits, vegetables, tea, and herbs. There is no consensus on an optimal intake level, and no authoritative dietary reference intake categories (AI, RDA, or UL) exist for quercetin. In research contexts, supplemental quercetin is often administered at doses of 250 mg up to 1000 mg per day for periods of weeks to months to evaluate biological effects, with higher doses explored in clinical settings; however, the safety of long‑term high‑dose supplementation remains uncertain. Individuals with robust diets rich in diverse plant foods typically achieve quercetin exposures at the lower end of these ranges without needing supplements. Factors influencing quercetin exposure needs include dietary patterns, genetic differences in metabolism, microbiome interactions, health status, and specific research outcomes of interest. Because quercetin is not essential, health authorities do not recommend specific intake targets for age or sex groups. Instead, the emphasis is on consuming a variety of flavonoid‑rich foods as part of overall dietary patterns associated with health, such as the Mediterranean diet, which is inherently rich in polyphenols including quercetin.

Unlike essential vitamins and minerals, quercetin does not have a recognized deficiency syndrome, and clinical signs of inadequate intake have not been established. Because quercetin is not required to prevent a physiological deficiency disease, health practitioners do not diagnose quercetin deficiency with blood tests or clinical criteria. Populations with low intakes of fruits, vegetables, tea, and herbs may have lower circulating levels of quercetin and other flavonoids, but this is interpreted within broader dietary quality assessments rather than specific nutrient deficiency. Indirectly, low intake of antioxidant phytonutrients may be associated with increased oxidative stress and related markers in observational studies, but such findings reflect overall dietary patterns rather than isolated quercetin deficiency. Researchers sometimes measure plasma quercetin levels in clinical studies, but no standardized reference ranges for deficiency or optimal concentrations have been universally accepted. As a consequence, medical guidance focuses on ensuring a diet rich in a variety of plant foods that provide quercetin along with other beneficial phytonutrients rather than correcting a specific deficiency of quercetin itself.

Quercetin is abundant in many plant foods, particularly in the outer layers or skins of fruits and vegetables and in herbs and spices. Concentrations vary widely due to plant species, growing conditions, and processing. Among the highest food sources documented are capers (notably high, with over 180 mg per 100 g), raw red onions (~30 mg/100 g), lovage leaves (~170 mg/100 g), and dill weed. Other vegetables with meaningful quercetin content include kale (~23 mg/100 g), broccoli (~30 mg/kg), watercress, and green beans, though content tends to be lower than in capers or herbs. Fruits such as blackberries, blueberries, cranberries, plums, and apples with skin provide quercetin in the single‑digit to low double‑digit mg per 100 g range. Beverages like brewed green and black tea contain smaller amounts but contribute to overall intake due to frequent consumption. Buckwheat and cocoa powder are grain/seed sources with noteworthy quercetin levels, and herbs like cilantro, parsley, and tarragon also offer phytonutrient density. Incorporating a wide range of these foods into daily meals can significantly increase quercetin intake from dietary sources rather than relying on supplements. Moreover, consuming foods with quercetin in whole‑food matrices may enhance its synergistic interactions with other nutrients that support health outcomes.

Quercetin’s absorption in humans is limited; studies indicate that its bioavailability is relatively low, often below 10% of ingested amounts due to poor water solubility and rapid metabolism. In foods, quercetin is largely present as glycosides — quercetin attached to sugars — which influences absorption. The type of sugar moiety affects transport across the gut lining and subsequent metabolism by intestinal enzymes and microbiota. Once absorbed, quercetin undergoes extensive conjugation in the liver, forming glucuronides, sulfates, and methylated derivatives that circulate in plasma. Strategies explored to enhance bioavailability include co‑administration with lipids, phospholipid complexes, encapsulation technologies, and combination with other nutrients like vitamin C or bromelain, which may stabilize quercetin and facilitate uptake. Food matrix and preparation methods also affect absorption; for example, raw onions and capers with intact glycosides may yield different bioavailability than processed forms. Interindividual variation in gut microbiome composition also influences quercetin metabolism and systemic exposure.

Quercetin supplements are widely available in capsules, tablets, powders, and phytosome or liposomal forms designed to enhance absorption. Some products combine quercetin with bromelain, vitamin C, or lecithin to potentially improve bioavailability and therapeutic impact. Clinical research often uses supplemental doses between 250 and 1000 mg per day for up to several weeks to assess effects on blood pressure, inflammation markers, or allergy symptoms, with mixed results. Individuals with limited dietary intake of fruits and vegetables may consider supplements as a way to increase phytonutrient exposure, but evidence is not conclusive that supplements confer clear clinical benefits beyond whole‑food consumption. Healthcare providers may discuss quercetin supplementation for specific conditions, but it should complement — not replace — a nutrient‑rich diet and established medical therapies. Because supplements are not strictly regulated by the FDA, product quality varies; choosing products tested by independent third parties can enhance safety. Pregnant or breastfeeding individuals should avoid high‑dose quercetin supplements due to limited safety data, and anyone with medical conditions or taking medications should consult their provider before supplement use.

No official tolerable upper intake level (UL) for quercetin has been set by regulatory authorities because it is not an essential nutrient and because adverse effects at typical dietary intakes are not observed. The FDA considers high‑purity quercetin as generally recognized as safe (GRAS) in foods at levels up to 500 mg per serving, but this designation applies to ingredient use rather than supplemental doses. Research studies using supplemental quercetin up to 1000 mg daily for up to 12 weeks have reported relatively good tolerability, but mild side effects such as gastrointestinal upset, headaches, or tingling sensations have been described. Long‑term safety of high‑dose supplementation remains under investigation, and individuals with kidney problems may be at increased risk of negative effects. Because quercetin undergoes extensive liver metabolism and can modulate enzymes involved in drug metabolism (cytochrome P450), high intakes from supplements could theoretically alter pharmaceutical drug levels. As with any bioactive compound, moderation and professional guidance are prudent when considering high supplemental doses.

Quercetin has the potential to interact with various medications through effects on drug‑metabolizing enzymes and transporters. It may influence cytochrome P450 enzymes such as CYP3A4, CYP2C9, and CYP2D6, which are responsible for the metabolism of many drugs, potentially altering their effectiveness or side‑effect profiles. Quercetin has been reported to interact with certain antibiotics (e.g., quinolones), immunosuppressants like cyclosporine, antihypertensives, and statins, potentially affecting plasma concentrations or therapeutic outcomes. It may also interact with anticoagulants such as warfarin, necessitating careful monitoring. Because quercetin can modulate organic anion transporters in the kidney, concurrent use with drugs dependent on these pathways requires caution. Patients taking prescription medications should consult healthcare professionals before initiating quercetin supplements to assess interaction risks and appropriate monitoring.

Common Forms: standard quercetin caplets, quercetin phytosome, liposomal quercetin

Typical Doses: 250–1000 mg daily in research settings

When to Take: with meals to improve absorption

Best Form: phytosome or liposomal formulations with enhanced bioavailability

⚠️ Interactions: CYP3A4 substrates, warfarin, antihypertensives